Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2013. Start Trial.
Date Value
October 23, 2026 0.7742
October 22, 2026 0.7625
October 21, 2026 0.8246
October 20, 2026 0.8745
October 19, 2026 0.931
October 16, 2026 0.77
October 15, 2026 0.8321
October 14, 2026 0.6853
October 13, 2026 0.7436
October 12, 2026 0.8039
October 09, 2026 0.8255
October 08, 2026 0.7653
October 07, 2026 0.8119
October 06, 2026 0.7898
October 05, 2026 0.8415
October 02, 2026 0.8208
October 01, 2026 0.8321
September 30, 2026 0.8754
September 29, 2026 0.915
September 28, 2026 0.9234
September 25, 2026 0.9183
September 24, 2026 0.947
September 23, 2026 0.9093
September 22, 2026 0.946
September 21, 2026 0.883
Date Value
September 18, 2026 0.8623
September 17, 2026 0.9296
September 16, 2026 0.9526
September 15, 2026 0.9649
September 14, 2026 1.039
September 11, 2026 1.064
September 10, 2026 1.024
September 09, 2026 0.995
September 08, 2026 1.032
September 04, 2026 1.080
September 03, 2026 1.020
September 02, 2026 0.9554
September 01, 2026 0.9762
August 31, 2026 0.9818
August 28, 2026 1.007
August 27, 2026 0.8481
August 26, 2026 0.8566
August 25, 2026 0.7408
August 24, 2026 0.7032
August 21, 2026 0.7389
August 20, 2026 0.7333
August 19, 2026 0.7436
August 18, 2026 0.7436
August 17, 2026 0.7079
August 14, 2026 0.7098

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
DBV Technologies SA 2.776
Cellectis SA 2.403
Bicycle Therapeutics Plc 0.4857
argenx SE --
Autolus Therapeutics Plc 7.307

Price to Book Value Related Metrics

PEG Ratio -0.0007
Price 8.225
Earnings Yield -240.4%
Market Cap 14.40M
PEGY Ratio -0.0007